1. Home
  2. Analysis
  3. Lanoxin
  4. Atrioventricular-block-first-degree

Lanoxin and Atrioventricular block first degree - a phase IV clinical study of FDA data

Summary:

Atrioventricular block first degree is reported as a side effect among people who take Lanoxin (digoxin), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Coumadin, and have High blood pressure.

The phase IV clinical study analyzes which people have Atrioventricular block first degree when taking Lanoxin. It is created by eHealthMe based on reports of 21,602 people who have side effects when taking Lanoxin from the FDA, and is updated regularly.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

What is Atrioventricular block first degree?

Atrioventricular block first degree (heart block first degree) is found to be associated with 646 drugs and 893 conditions by eHealthMe. Check the latest studies of Atrioventricular block first degree.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

21,602 people reported to have side effects when taking Lanoxin.
Among them, 108 people (0.5%) have Atrioventricular block first degree.

Could Lanoxin cause Atrioventricular block first degree?

Among these 108 people:

How long have people been on Lanoxin when they have Atrioventricular block first degree? *

What is the gender of people who have Atrioventricular block first degree when taking Lanoxin? *

Click here to view

What is the age of people who have Atrioventricular block first degree when taking Lanoxin? *

What are other drugs people take besides Lanoxin? *

Click here to view

What are other side effects people have besides Atrioventricular block first degree? *

Click here to view

What are the existing conditions these people have? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxin and have Atrioventricular block first degree?

- Check whether Atrioventricular block first degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lanoxin:

Atrioventricular block first degree treatments and more:

How severe was Atrioventricular block first degree and when was it recovered:

Expand to all the drugs that have ingredients of digoxin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lanoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrioventricular block first degree:

Browse all the conditions that are associated with Atrioventricular block first degree:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on digoxin (the active ingredients of Lanoxin) and Lanoxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.